BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10811940)

  • 1. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
    Inman GJ; Allday MJ
    J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines.
    Fukuda M; Ikuta K; Yanagihara K; Tajima M; Kuratsune H; Kurata T; Sairenji T
    Virology; 2001 Sep; 288(1):109-18. PubMed ID: 11543663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
    Mori N; Morishita M; Tsukazaki T; Yamamoto N
    Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
    Arvanitakis L; Yaseen N; Sharma S
    J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A; Pfaff P; Lange W; Finke J
    Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
    Perez-Chacon G; de Los Rios C; Zapata JM
    Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
    Evans TJ; Jacquemin MG; Farrell PJ
    Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
    J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
    Kumar A; Rogers T; Maizel A; Sharma S
    J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines.
    Sinclair AJ; Jacquemin MG; Brooks L; Shanahan F; Brimmell M; Rowe M; Farrell PJ
    Virology; 1994 Mar; 199(2):339-53. PubMed ID: 8122366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines.
    Chaouchi N; Arvanitakis L; Auffredou MT; Blanchard DA; Vazquez A; Sharma S
    Oncogene; 1995 Oct; 11(8):1615-22. PubMed ID: 7478586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
    Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ
    J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
    Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
    J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.